未登录

E

Ewa Piotrowska

University of Gdansk

H指数:21

被引数:1,343

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: Topical application of the HSP90 inhibitor 17-AAG reduces skin inflammation and partially restores microbial balance: implications for atopic dermatitis therapy

作者更正：局部应用HSP90抑制剂17-AAG可减轻皮肤炎症并部分恢复微生物平衡：对特应性皮炎治疗的启示

Scientific Reports

IF3.9

2026-04-020

OAAI

Hyaluronan in mesenchymal stromal cell lineage differentiation from human pluripotent stem cells: application in serum free culture

STEM CELL RESEARCH & THERAPY

IF7.3

2024-05-030

OAAI

Therapeutic potential of lithium chloride and valproic acid against neuronopathic types of mucopolysaccharidoses through induction of the autophagy process

氯化锂和丙戊酸通过诱导自噬过程对神经病变类型的粘多糖的治疗潜力

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

IF3

2023-10-011

OAAI

Behavioral- and blood-based biomarkers for Huntington's disease: Studies on the R6/1 mouse model with prospects for early diagnosis and monitoring of the disease

brain behavior and immunity

IF3.5

2022-08-017

OAAI

Changes in expressions of genes involved in the regulation of cellular processes in mucopolysaccharidoses as assessed by fibroblast culture-based transcriptomic analyses

METABOLIC BRAIN DISEASE

IF3.5

2020-09-0413

OAAI

Autoantibodies to heat shock proteins 60, 70, and 90 in patients with rheumatoid arthritis

CELL STRESS & CHAPERONES

IF3.2

2019-01-0141

OAAI

Autophagy stimulation as a promising approach in treatment of neurodegenerative diseases

自噬刺激在神经退行性疾病治疗中的应用前景

METABOLIC BRAIN DISEASE

IF3.5

2018-03-1462

OAAI

Inhibition of Shiga toxin-converting bacteriophage development by novel antioxidant compounds

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

IF5.4

2018-03-1410

OAAI

How close are we to therapies for Sanfilippo disease?

METABOLIC BRAIN DISEASE

IF3.5

2017-09-1853

OAAI

Effects of flavonoids on expression of genes involved in cell cycle regulation and DNA replication in human fibroblasts (vol 407, pg 97, 2015)

MOLECULAR AND CELLULAR BIOCHEMISTRY

IF3.7

2016-10-280

OAAI

Glycosaminoglycans and mucopolysaccharidosis type III

FRONTIERS IN BIOSCIENCE-LANDMARK

IF3.1

2016-01-0135

OAAI

Effects of flavonoids on expression of genes involved in cell cycle regulation and DNA replication in human fibroblasts

MOLECULAR AND CELLULAR BIOCHEMISTRY

IF3.7

2015-05-2419

OAAI

Mucopolysaccharidosis Type VI (Maroteaux-Lamy Syndrome) With A Predominantly Cardiac Phenotype

MOLECULAR GENETICS AND METABOLISM

IF3.5

2012-02-010

PREAI

Molecular analysis of mucopolysaccharidosis type VI in Poland, Belarus, Lithuania and Estonia

MOLECULAR GENETICS AND METABOLISM

IF3.5

2012-02-0128

PREAI

Mucopolysaccharidosis Type VI (Maroteaux-Lamy syndrome) with a predominantly cardiac phenotype

MOLECULAR GENETICS AND METABOLISM

IF3.5

2011-12-0123

PREAI

Genistein: a natural isoflavone with a potential for treatment of genetic diseases

BIOCHEMICAL SOCIETY TRANSACTIONS

IF4.3

2010-03-2253

OAAI

Different Amounts of Isoflavones in Various Commercially Available Soy Extracts in the Light of Gene Expression-targeted Isoflavone Therapy

PHYTOTHERAPY RESEARCH

IF6.3

2010-01-1419

PREAI

Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway

JOURNAL OF BIOMEDICAL SCIENCE

IF12.1

2009-03-02104

OAAI

Abnormalities in the hair morphology of patients with some but not all types of mucopolysaccharidoses

EUROPEAN JOURNAL OF PEDIATRICS

IF2.6

2007-03-1523

PREAI

Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses

EUROPEAN JOURNAL OF HUMAN GENETICS

IF4.6

2006-05-03165

OAAI